Devoted to Advancements in Neuroscience

Our Vision

To be the North American leader in neurology through the quality of our people, the quality of our products and our focus on the patient.

Our Values

  • Personal commitment
  • High Integrity
  • Focus on Achievement
  • Shared Sense of Satisfaction
  • Strong Teamwork
  • Creation of Opportunities

At Teva Neuroscience, we are dedicated to improving the lives of people with neurological and auto-immune diseases.

While the vision first inspired research in the area of Multiple Sclerosis (MS), a condition to which Teva Neuroscience has been dedicated since its foundation in 1997, our development and commercialization efforts have since grown to encompass Parkinson’s disease, migraine, Alzheimer’s disease and systemic lupus erythematosus. However, our vision has remained constant: to be the North American leader in neurology through the quality of our people and products and our focus on the patient. That vision and hope for the future, and the people who live with these debilitating diseases, give meaning to everything we do.

We know that our success relies greatly on the quality of our people. They make Teva Neuroscience what it is, bringing our vision to life every day through remarkable work, ongoing commitment to patients, dedication and perseverance. We are proud of the tremendous knowledge, talent and experience of our people, all working toward making life better for people with neurological and auto-immune diseases.

RESPECT is the cornerstone of our culture

  • For the core purpose of our industry, which is to improve the lives of people affected with health conditions;
  • For health professionals;
  • For patients, their families and caregivers;
  • For our colleagues;
  • For the community;
  • For the environment.

Teva Neuroscience’s future includes continuing to innovate in the treatment of neurological and auto-immune disorders. Research is opening new medical frontiers and bringing hope to millions of people every year. We hope you will share our passion and pride to be a part of those exciting possibilities to make a difference in the lives of people living with these devastating diseases.

Jean Godin, M.D.
General Manager
Teva Neuroscience



Results of ADAGIO Study with Azilect® in Parkinson’s Disease Published in New England Journal of Medicine.

Learn more

Teva Pharmaceutical Industries Ltd. Press Release

New England Journal of Medicine